Benzenecarboximidamide, 2-ethoxy-, hydrochloride (1:1)

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

April 2000

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: GLP guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2000

Report date:

2000

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Deviations:

no

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU Method B.1 (Acute Toxicity (Oral))

Deviations:

no

GLP compliance:

yes

Test type:

acute toxic class method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

2-ethoxybenzenecarboximidamide hydrochloride

EC Number:

606-080-9

Cas Number:

18637-00-8

Molecular formula:

C9 H12 N2 O . Cl H

IUPAC Name:

2-ethoxybenzenecarboximidamide hydrochloride

Test animals

Species:

rat

Strain:

Wistar

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Harlan Winkelmann, Borchen, Germany
- Strain: Hsd Cpb:WU (SPF)
- Age at study initiation: 8-9 weeks
- Mean weight at study initiation: 219-237 g (males) or 163-174 g (females)
- Housing: in groups of 3 animals
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): approx. 55 +/- 5
- Air changes (per hr): approx. 15-20
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

water

Remarks:

demineralized

Details on oral exposure:

- Application volume: 10 mL/kg bw

- Rationale for the selection of the starting dose:
As described in the flow charts of Annex 2, OECD guideline 423, the starting dose level should be that which is most likely to produce mortality in
some of the dosed animals. Therefore, the limit dose 2000 mg/kg bw was chosen as starting dose.

Doses:

200 mg/kg (males and females), 2000 mg/kg (females)

No. of animals per sex per dose:

3

Control animals:

no

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: at least once daily (clinical signs, mortality) or once weekly (weight gain)
- Necropsy of survivors performed: yes

Statistics:

none

Results and discussion

Effect levels

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 300 - < 500 mg/kg bw

Based on:

test mat.

Mortality:

The dose of 2000 mg/kg bw was lethal in females. All females died between 10 and 15 minutes after administration. All males and females of the dose group 200 mg/kg bw survived

Clinical signs:

other: At 200 mg/kg bw the motility and reactivity were decreased , the gait uncoordinated, breathing labored and salivation increased. The signs observed sarted directly after administration and lasted within 6 hours after administration. Additionally to the s

Gross pathology:

In the female animals that died during the observation period a dark-red discoloration of liver was detected. The animals sacrificed at the end of the study showed no gross pathological findings.

Other findings:

none

Applicant's summary and conclusion

Interpretation of results:

harmful

Remarks:

Migrated information

Executive summary:

The acute oral toxicity of Ethoxyamidin Hydrochloride was moderate with an LD50 value of > 300 < 500 mg/kg bw in rats according to OECD TG 423 (1996). All females died after oral ingestion of 2000 mg/kg bw. All males and females dosed with 200 mg/kg bw survived. Clinical signs were observed at 200 mg/kg bw and above in both genders. Body weight development was not affected at 200 mg/kg bw. In animals that died during the observation period a dark-red discoloration of the liver was detected.